Algal Phlorotannins as Novel Antibacterial Agents with Reference to the Antioxidant Modulation: Current Advances and Future Directions

Mar Drugs. 2022 Jun 18;20(6):403. doi: 10.3390/md20060403.

Abstract

The increasing drug resistance of infectious microorganisms is considered a primary concern of global health care. The screening and identification of natural compounds with antibacterial properties have gained immense popularity in recent times. It has previously been shown that several bioactive compounds derived from marine algae exhibit antibacterial activity. Similarly, polyphenolic compounds are generally known to possess promising antibacterial capacity, among other capacities. Phlorotannins (PTs), an important group of algae-derived polyphenolic compounds, have been considered potent antibacterial agents both as single drug entities and in combination with commercially available antibacterial drugs. In this context, this article reviews the antibacterial properties of polyphenols in brown algae, with particular reference to PTs. Cell death through various molecular modes of action and the specific inhibition of biofilm formation by PTs were the key discussion of this review. The synergy between drugs was also discussed in light of the potential use of PTs as adjuvants in the pharmacological antibacterial treatment.

Keywords: antibacterial activity; antibiotic; antioxidant; brown algae; marine algae; phlorotannin; polyphenols.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Antioxidants* / pharmacology
  • Phaeophyceae*
  • Polyphenols / pharmacology
  • Tannins / pharmacology

Substances

  • Anti-Bacterial Agents
  • Antioxidants
  • Polyphenols
  • Tannins

Grants and funding

This research received no external funding.